Skip to Main Content

Paper Details

Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer.
Breast Cancer Research and Treatment
3
2021
Aromatase, ER, ER-positive/HER2-negative breast cancer, HER2, Ki67, NET, luminal tumor, patients, trastuzumab, tumor, tumors
Author NameAffiliation
Matthew J EllisLester and Sue Smith Breast Cancer Center, Baylor College of Medicine
  • 1 - 1

Datasets

Release 1.2